{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:02:52Z","timestamp":1780995772273,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shanghai Top-Priority Medical Center Construction Project","award":["2023ZZ02022"],"award-info":[{"award-number":["2023ZZ02022"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507502"],"award-info":[{"award-number":["2023YFC2507502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#82470612"],"award-info":[{"award-number":["#82470612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-026-09167-1","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:33:35Z","timestamp":1780994015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development"],"prefix":"10.1007","volume":"69","author":[{"given":"Haoyu","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiting","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrui","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuxiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"issue":"2","key":"9167_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.03.017","volume":"83","author":"G Dalekos","year":"2025","unstructured":"Dalekos G, Gatselis N, Drenth JP et al (2025) EASL clinical practice guidelines on the management of autoimmune hepatitis. J Hepatol S0168827825001734. https:\/\/doi.org\/10.1016\/j.jhep.2025.03.017","journal-title":"J Hepatol"},{"issue":"3","key":"9167_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/liv.15829","volume":"44","author":"M Ferronato","year":"2024","unstructured":"Ferronato M, Lalanne C, Quarneti C et al (2024) The evolving phenotype of autoimmune hepatitis across the millennium: The 40-year experience of a referral centre in Italy. Liver Int 44(3):791\u2013798. https:\/\/doi.org\/10.1111\/liv.15829","journal-title":"Liver Int"},{"key":"9167_CR3","doi-asserted-by":"publisher","unstructured":"Y S, F K, Y Y, O S, N M, Y O (2011) Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol. https:\/\/doi.org\/10.1007\/s00535-010-0316-3","DOI":"10.1007\/s00535-010-0316-3"},{"issue":"12","key":"9167_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-008-2254-x","volume":"43","author":"K Fujiwara","year":"2008","unstructured":"Fujiwara K, Fukuda Y, Yokosuka O (2008) Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J Gastroenterol 43(12):951\u2013958. https:\/\/doi.org\/10.1007\/s00535-008-2254-x","journal-title":"J Gastroenterol"},{"issue":"3","key":"9167_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","volume":"79","author":"RJ Andrade","year":"2023","unstructured":"Andrade RJ, Aithal GP, De Boer YS et al (2023) Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report. J Hepatol 79(3):853\u2013866. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.033","journal-title":"J Hepatol"},{"issue":"5","key":"9167_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.12.041","volume":"82","author":"MA Heneghan","year":"2025","unstructured":"Heneghan MA, Lohse AW (2025) Update in clinical science: autoimmune hepatitis. J Hepatol S0168827824028320. https:\/\/doi.org\/10.1016\/j.jhep.2024.12.041","journal-title":"J Hepatol"},{"issue":"6","key":"9167_CR7","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bj\u00f6rnsson","year":"2010","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S et al (2010) Drug-induced autoimmune hepatitis: Clinical characteristics and prognosis. Hepatology 51(6):2040\u20132048. https:\/\/doi.org\/10.1002\/hep.23588","journal-title":"Hepatology"},{"issue":"3","key":"9167_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/apt.70353","volume":"63","author":"P Arvaniti","year":"2025","unstructured":"Arvaniti P, Olivas I, Pascual-Dapena A et al (2025) Unveiling drug\u2010induced autoimmune\u2010like hepatitis in autoimmune hepatitis patients: a multicenter retrospective study. Aliment Pharmacol Ther apt.70353. https:\/\/doi.org\/10.1111\/apt.70353","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"9167_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ueg2.12499","volume":"12","author":"Y Chung","year":"2024","unstructured":"Chung Y, Morrison M, Zen Y, Heneghan MA (2024) Defining characteristics and long-term prognosis of drug\u2010induced autoimmune\u2010like hepatitis: A retrospective cohort study. United Eur Gastroenterol J 12(1):66\u201375. https:\/\/doi.org\/10.1002\/ueg2.12499","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"9167_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/hep.24481","volume":"54","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Brunt EM, Kleiner DE et al (2011) The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 54(3):931\u2013939. https:\/\/doi.org\/10.1002\/hep.24481","journal-title":"Hepatology"},{"issue":"8","key":"9167_CR11","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/liv.15623","volume":"43","author":"M Garc\u00eda-Cort\u00e9s","year":"2023","unstructured":"Garc\u00eda-Cort\u00e9s M, Ortega\u2010Alonso A, Matilla\u2010Cabello G et al (2023) Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries. Liver Int 43(8):1749\u20131760. https:\/\/doi.org\/10.1111\/liv.15623","journal-title":"Liver Int"},{"issue":"6","key":"9167_CR12","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"RJ Andrade","year":"2019","unstructured":"Andrade RJ, Aithal GP, Bj\u00f6rnsson ES et al (2019) EASL clinical practice guidelines: drug-induced liver injury. J Hepatol 70(6):1222\u20131261. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.014","journal-title":"J Hepatol"},{"key":"9167_CR13","doi-asserted-by":"publisher","unstructured":"Fontana RJ, Liou I, Reuben A et al (2022) AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. https:\/\/doi.org\/10.1002\/hep.32689. Published online July 27","DOI":"10.1002\/hep.32689"},{"issue":"2","key":"9167_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN et al (2020) Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases. Hepatology 72(2):671\u2013722. https:\/\/doi.org\/10.1002\/hep.31065","journal-title":"Hepatology"},{"key":"9167_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1959","author":"ES Bjornsson","year":"2022","unstructured":"Bjornsson ES, Medina-Caliz I, Andrade RJ, Lucena MI (2022) Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports. Hepatol Commun. https:\/\/doi.org\/10.1002\/hep4.1959","journal-title":"Hepatol Commun"},{"issue":"5","key":"9167_CR16","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/liv.15217","volume":"42","author":"AW Lohse","year":"2022","unstructured":"Lohse AW, Sebode M, Bhathal PS et al (2022) Consensus recommendations for histological criteria of autoimmune hepatitis from the international AIH pathology group. Liver Int 42(5):1058\u20131069. https:\/\/doi.org\/10.1111\/liv.15217","journal-title":"Liver Int"},{"key":"9167_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/his.70027","author":"Z Ma","year":"2025","unstructured":"Ma Z, Wang L, Liu J et al (2025) The validation of histological criteria from the IAIH-PG to distinguish AIH from drug-induced liver injury. Histopathology. n\/a(n\/a). https:\/\/doi.org\/10.1111\/his.70027","journal-title":"Histopathology"},{"key":"9167_CR18","doi-asserted-by":"publisher","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","volume":"380","author":"L Muratori","year":"2023","unstructured":"Muratori L, Lohse AW, Lenzi M (2023) Diagnosis and management of autoimmune hepatitis. BMJ 380:e070201. https:\/\/doi.org\/10.1136\/bmj-2022-070201","journal-title":"BMJ"},{"issue":"3","key":"9167_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.aohep.2018.09.001","volume":"18","author":"AA Aljumah","year":"2019","unstructured":"Aljumah AA, Al-Ashgar H, Fallatah H, Albenmousa A (2019) Acute onset autoimmune hepatitis: clinical presentation and treatment outcomes. Ann Hepatol 18(3):439\u2013444. https:\/\/doi.org\/10.1016\/j.aohep.2018.09.001","journal-title":"Ann Hepatol"},{"issue":"5","key":"9167_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/s0168-8278(94)80251-3","volume":"21","author":"GA Nikias","year":"1994","unstructured":"Nikias GA, Batts KP, Czaja AJ (1994) The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 21(5):866\u2013871. https:\/\/doi.org\/10.1016\/s0168-8278(94)80251-3","journal-title":"J Hepatol"},{"key":"9167_CR21","doi-asserted-by":"publisher","first-page":"6470847","DOI":"10.1155\/2022\/6470847","volume":"2022","author":"A Urzua","year":"2022","unstructured":"Urzua A, Pizarro C, Gajardo A et al (2022) Autoimmune hepatitis with acute presentation: clinical, biochemical, and histological features of 126 patients. Can J Gastroenterol Hepatol 2022:6470847. https:\/\/doi.org\/10.1155\/2022\/6470847","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"6","key":"9167_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ et al (2011) Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 89(6):806\u2013815. https:\/\/doi.org\/10.1038\/clpt.2011.58","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"9167_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","volume":"74","author":"J Galaski","year":"2021","unstructured":"Galaski J, Weiler-Normann C, Schakat M et al (2021) Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing. J Hepatol 74(2):312\u2013320. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.032","journal-title":"J Hepatol"},{"key":"9167_CR24","doi-asserted-by":"publisher","unstructured":"Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696\u2013699. https:\/\/doi.org\/10.1016\/0168-8278(95)80226-6","DOI":"10.1016\/0168-8278(95)80226-6"},{"issue":"1","key":"9167_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"The french METAVIR cooperative study group","year":"1994","unstructured":"The french METAVIR cooperative study group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatol (baltim Md,) 20(1):15\u201320","journal-title":"Hepatol (baltim Md,)"},{"issue":"11","key":"9167_CR26","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46(11):1323\u20131330. https:\/\/doi.org\/10.1016\/0895-4356(93)90101-6","journal-title":"J Clin Epidemiol"},{"key":"9167_CR27","doi-asserted-by":"publisher","unstructured":"Hayashi PH, Lucena MI, Fontana RJ et al (2022) A revised electronic version of RUCAM for the diagnosis of drug induced liver injury. Hepatology Published online January 11. https:\/\/doi.org\/10.1002\/hep.32327","DOI":"10.1002\/hep.32327"},{"issue":"5","key":"9167_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/s0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB et al (1999) International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31(5):929\u2013938. https:\/\/doi.org\/10.1016\/s0168-8278(99)80297-9","journal-title":"J Hepatol"},{"issue":"1","key":"9167_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48(1):169\u2013176. https:\/\/doi.org\/10.1002\/hep.22322","journal-title":"Hepatology"},{"issue":"8","key":"9167_CR30","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s10620-011-1786-8","volume":"56","author":"A Heurgue-Berlot","year":"2011","unstructured":"Heurgue-Berlot A, Bernard-Chabert B, Diebold MD, Thiefin G (2011) Drug-induced autoimmune-like hepatitis: a case of chronic course after drug withdrawal. Dig Dis Sci 56(8):2504\u20132505. https:\/\/doi.org\/10.1007\/s10620-011-1786-8","journal-title":"Dig Dis Sci"},{"issue":"2","key":"9167_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16239","volume":"45","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lin X, Sun Y et al (2025) Development and validation of a novel model to discriminate idiosyncratic drug-induced liver injury and autoimmune hepatitis. Liver Int 45(2):e16239. https:\/\/doi.org\/10.1111\/liv.16239","journal-title":"Liver Int"},{"issue":"1","key":"9167_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.023","volume":"81","author":"A Alkashash","year":"2024","unstructured":"Alkashash A, Zhang X, Vuppalanchi R, Lammert C, Saxena R (2024) Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: the answer lies at the interface. J Hepatol (1):S0168-8278(24)100-4. https:\/\/doi.org\/10.1016\/j.jhep.2024.01.023","journal-title":"J Hepatol"},{"issue":"10","key":"9167_CR33","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/liv.14195","volume":"39","author":"S Weber","year":"2019","unstructured":"Weber S, Benesic A, Rotter I, Gerbes AL (2019) Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis. Liver Int 39(10):1906\u20131917. https:\/\/doi.org\/10.1111\/liv.14195","journal-title":"Liver Int"},{"issue":"11","key":"9167_CR34","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep4.1582","volume":"4","author":"C Lammert","year":"2020","unstructured":"Lammert C, Zhu C, Lian Y et al (2020) Exploratory study of autoantibody profiling in drug-induced liver injury with an autoimmune phenotype. Hepatol Commun 4(11):1651\u20131663. https:\/\/doi.org\/10.1002\/hep4.1582","journal-title":"Hepatol Commun"},{"issue":"3","key":"9167_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092267","volume":"9","author":"WC Zhang","year":"2014","unstructured":"Zhang WC, Zhao FR, Chen J, Chen WX (2014) Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen\/liver pancreas in autoimmune hepatitis. PLoS One 9(3):e92267. https:\/\/doi.org\/10.1371\/journal.pone.0092267","journal-title":"PLoS One"},{"issue":"3","key":"9167_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portmann B, Reid F et al (1997) Autoimmune hepatitis in childhood: a 20\u2013year experience. Hepatology 25(3):541\u2013547. https:\/\/doi.org\/10.1002\/hep.510250308","journal-title":"Hepatology"},{"issue":"2","key":"9167_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","volume":"15","author":"G Wang","year":"2021","unstructured":"Wang G, Tanaka A, Zhao H et al (2021) The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 15(2):223\u2013257. https:\/\/doi.org\/10.1007\/s12072-021-10170-1","journal-title":"Hepatol Int"},{"key":"9167_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","volume":"41","author":"Q Wang","year":"2013","unstructured":"Wang Q, Selmi C, Zhou X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140\u2013145. https:\/\/doi.org\/10.1016\/j.jaut.2012.10.004","journal-title":"J Autoimmun"},{"issue":"4","key":"9167_CR39","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","volume":"108","author":"SR Targan","year":"1995","unstructured":"Targan SR, Landers C, Vidrich A, Czaja AJ (1995) High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 108(4):1159\u20131166. https:\/\/doi.org\/10.1016\/0016-5085(95)90215-5","journal-title":"Gastroenterology"},{"issue":"2","key":"9167_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.semarthrit.2017.03.021","volume":"47","author":"S Engelhart","year":"2017","unstructured":"Engelhart S, Glynn RJ, Schur PH (2017) Disease associations with isolated elevations of each of the four IgG subclasses. Semin Arthritis Rheum 47(2):276\u2013280. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.03.021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"9167_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/etm.2020.9476","volume":"21","author":"W Zheng","year":"2021","unstructured":"Zheng W, Jiang F, Shan J et al (2021) Levels of serum IgG subclasses in patients with liver disease: A retrospective study. Exp Ther Med 21(1):45. https:\/\/doi.org\/10.3892\/etm.2020.9476","journal-title":"Exp Ther Med"},{"issue":"1","key":"9167_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/hep.32134","volume":"75","author":"R Taubert","year":"2022","unstructured":"Taubert R, Engel B, Diestelhorst J et al (2022) Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis. Hepatology 75(1):13\u201327. https:\/\/doi.org\/10.1002\/hep.32134","journal-title":"Hepatology"},{"key":"9167_CR43","doi-asserted-by":"publisher","unstructured":"L W SY (2012) Critical role of interleukin-17\/interleukin-17 receptor axis in mediating con a-induced hepatitis. Immunol Cell Biol 90(4). https:\/\/doi.org\/10.1038\/icb.2011.59","DOI":"10.1038\/icb.2011.59"},{"key":"9167_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1037645","volume":"13","author":"SM Morris","year":"2022","unstructured":"Morris SM, Chauhan A (2022) The role of platelet mediated thromboinflammation in acute liver injury. Front Immunol 13:1037645. https:\/\/doi.org\/10.3389\/fimmu.2022.1037645","journal-title":"Front Immunol"},{"issue":"6","key":"9167_CR45","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/liv.13317","volume":"37","author":"M Peck-Radosavljevic","year":"2017","unstructured":"Peck-Radosavljevic M (2017) Thrombocytopenia in chronic liver disease. Liver Int 37(6):778\u2013793. https:\/\/doi.org\/10.1111\/liv.13317","journal-title":"Liver Int"},{"key":"9167_CR46","doi-asserted-by":"publisher","unstructured":"Weber S, Gerbes AL (2023) Relapse and need for extended immunosuppression: novel features of drug-induced autoimmune hepatitis. Digestion 1421\u20139867. https:\/\/doi.org\/10.1159\/000528329","DOI":"10.1159\/000528329"},{"issue":"1","key":"9167_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","volume":"15","author":"YS de Boer","year":"2017","unstructured":"de Boer YS, Kosinski AS, Urban TJ et al (2017) Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol 15(1):103-112 e2. https:\/\/doi.org\/10.1016\/j.cgh.2016.05.043","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"9167_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.14218\/JCTH.2018.00053","volume":"7","author":"CA Febres-Aldana","year":"2019","unstructured":"Febres-Aldana CA, Alghamdi S, Krishnamurthy K, Poppiti RJ (2019) Liver fibrosis helps to distinguish autoimmune hepatitis from Dili with autoimmune features: a review of twenty cases. J Clin Transl Hepatol 7(1):21\u201326. https:\/\/doi.org\/10.14218\/JCTH.2018.00053","journal-title":"J Clin Transl Hepatol"},{"key":"9167_CR49","doi-asserted-by":"publisher","unstructured":"Wang L, Du ZX, Liu HL et al (2024) IAIH-PG consensus for histological criteria of AIH: multicentre validation with focus on chronic liver diseases in China. Liver Int. https:\/\/doi.org\/10.1111\/liv.15971 Published online May 22.","DOI":"10.1111\/liv.15971"},{"key":"9167_CR50","doi-asserted-by":"publisher","unstructured":"Ahn S, Jeong SH, Cho EJ, Lee K, Kim G, Kim H (2023) Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity. Clin Mol Hepatol 2287\u2013285X. https:\/\/doi.org\/10.3350\/cmh.2023.0325","DOI":"10.3350\/cmh.2023.0325"},{"issue":"11","key":"9167_CR51","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1111\/liv.15394","volume":"42","author":"F Colapietro","year":"2022","unstructured":"Colapietro F, Masetti C, Pugliese N, Lleo A (2022) Recommendations for histological criteria of autoimmune hepatitis from the international AIH pathology: validation on a monocentric cohort. Liver Int 42(11):2583\u20132584. https:\/\/doi.org\/10.1111\/liv.15394","journal-title":"Liver Int"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-026-09167-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:33:45Z","timestamp":1780994025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-026-09167-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9167"],"URL":"https:\/\/doi.org\/10.1007\/s12016-026-09167-1","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}